244 related articles for article (PubMed ID: 33385714)
1. Genome-wide analysis of Indian SARS-CoV-2 genomes to identify T-cell and B-cell epitopes from conserved regions based on immunogenicity and antigenicity.
Ghosh N; Sharma N; Saha I; Saha S
Int Immunopharmacol; 2021 Feb; 91():107276. PubMed ID: 33385714
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and antigenicity based T-cell and B-cell epitopes identification from conserved regions of 10664 SARS-CoV-2 genomes.
Ghosh N; Sharma N; Saha I
Infect Genet Evol; 2021 Aug; 92():104823. PubMed ID: 33819681
[TBL] [Abstract][Full Text] [Related]
3. Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening.
Waqas M; Haider A; Rehman A; Qasim M; Umar A; Sufyan M; Akram HN; Mir A; Razzaq R; Rasool D; Tahir RA; Sehgal SA
Biomed Res Int; 2021; 2021():1596834. PubMed ID: 33728324
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics pipeline unveils genetic variability to synthetic vaccine design for Indian SARS-CoV-2 genomes.
Ghosh N; Saha I; Sharma N; Nandi S
Int Immunopharmacol; 2022 Nov; 112():109224. PubMed ID: 36116149
[TBL] [Abstract][Full Text] [Related]
5. T and B cell Epitope analysis of SARS-CoV-2 S protein based on immunoinformatics and experimental research.
Chen Z; Ruan P; Wang L; Nie X; Ma X; Tan Y
J Cell Mol Med; 2021 Jan; 25(2):1274-1289. PubMed ID: 33325143
[TBL] [Abstract][Full Text] [Related]
6. Immunoinformatics prediction of overlapping CD8
Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
9. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
Front Immunol; 2021; 12():692937. PubMed ID: 34497604
[TBL] [Abstract][Full Text] [Related]
10. Landscape and selection of vaccine epitopes in SARS-CoV-2.
Smith CC; Olsen KS; Gentry KM; Sambade M; Beck W; Garness J; Entwistle S; Willis C; Vensko S; Woods A; Fini M; Carpenter B; Routh E; Kodysh J; O'Donnell T; Haber C; Heiss K; Stadler V; Garrison E; Sandor AM; Ting JPY; Weiss J; Krajewski K; Grant OC; Woods RJ; Heise M; Vincent BG; Rubinsteyn A
Genome Med; 2021 Jun; 13(1):101. PubMed ID: 34127050
[TBL] [Abstract][Full Text] [Related]
11. Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern.
Martín-Galiano AJ; Díez-Fuertes F; McConnell MJ; López D
Front Immunol; 2021; 12():732693. PubMed ID: 34899692
[TBL] [Abstract][Full Text] [Related]
12. A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation.
Marchan J
J Immunol Methods; 2022 Mar; 502():113216. PubMed ID: 35007561
[TBL] [Abstract][Full Text] [Related]
13. A Bioinformatics Approach for the Prediction of Immunogenic Properties and Structure of the SARS-COV-2 B.1.617.1 Variant Spike Protein.
Srivastava VK; Kaushik S; Bhargava G; Jain A; Saxena J; Jyoti A
Biomed Res Int; 2021; 2021():7251119. PubMed ID: 34651048
[TBL] [Abstract][Full Text] [Related]
14. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
15. Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches.
Tahir Ul Qamar M; Rehman A; Tusleem K; Ashfaq UA; Qasim M; Zhu X; Fatima I; Shahid F; Chen LL
PLoS One; 2020; 15(12):e0244176. PubMed ID: 33351863
[TBL] [Abstract][Full Text] [Related]
16. Immuno-informatics design of a multimeric epitope peptide based vaccine targeting SARS-CoV-2 spike glycoprotein.
Chukwudozie OS; Gray CM; Fagbayi TA; Chukwuanukwu RC; Oyebanji VO; Bankole TT; Adewole RA; Daniel EM
PLoS One; 2021; 16(3):e0248061. PubMed ID: 33730022
[TBL] [Abstract][Full Text] [Related]
17. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2.
Lin L; Ting S; Yufei H; Wendong L; Yubo F; Jing Z
Virus Res; 2020 Oct; 288():198082. PubMed ID: 32621841
[TBL] [Abstract][Full Text] [Related]
18. Immunoinformatic Analysis of SARS-CoV-2 Nucleocapsid Protein and Identification of COVID-19 Vaccine Targets.
Oliveira SC; de Magalhães MTQ; Homan EJ
Front Immunol; 2020; 11():587615. PubMed ID: 33193414
[TBL] [Abstract][Full Text] [Related]
19. Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach.
Hisham Y; Ashhab Y; Hwang SH; Kim DE
Viruses; 2021 Apr; 13(5):. PubMed ID: 33925069
[TBL] [Abstract][Full Text] [Related]
20. Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein.
He J; Huang F; Zhang J; Chen Q; Zheng Z; Zhou Q; Chen D; Li J; Chen J
J Med Virol; 2021 Apr; 93(4):2115-2131. PubMed ID: 33091154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]